The evidence for treating hypertension in older people with dementia: A systematic review

Journal of Human Hypertension

Volumn 28, Issue 5, 2014, Pages 283-287

  Beishon, L C ^a   Harrison, J K ^b   Harwood, R H ^c   Robinson, T G ^b   Gladman, J R F ^c   Conroy, S P ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

blood pressure; dementia; outcomes

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; ENALAPRIL; IMIDAPRIL; INDAPAMIDE; NIMODIPINE; PERINDOPRIL; TELMISARTAN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR MORTALITY; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE SEVERITY; DRUG FATALITY; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; HYPERTENSION; MINI MENTAL STATE EXAMINATION; MORBIDITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; AGED; COMPLICATION; EVIDENCE BASED MEDICINE;

AGED; ANTIHYPERTENSIVE AGENTS; DEMENTIA; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION;

EID: 84898545309     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.107     Document Type: Review

References (32)

1. Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Management of hypertension: summary of NICE guidance. BMJ 2011; 343: d4891.
2. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009(4): CD000028.pub 2.
3. Beckett NSPR, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V et al. For the HYVET Study Group: treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358(18): 1887-1898.
4. Law M, Morris J, Wald N. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338(33a): 1-19.
5. Barnes DE, Cauley JA, Lui LY, Fink HA, McCulloch C, Stone KL et al. Women who maintain optimal cognitive function into old age. J Am Geriatr Soc 2007; 55(2): 259-264.
6. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352(9137): 1347-1351.
7. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163: 1069-1075.
8. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B et al. The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization. J Hypertens Engl 2004; 22: 1605-1612.
9. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008; 7: 683-689.
10. Di Bari M, Pahor M, Franse LV, Shorr RI, Wan JY, Ferrucci L et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol 2001; 153(1): 72-78.
11. Birkenhager WH, Forette F, Staessen JA. Dementia and antihypertensive treatment. Curr Opin Nephrol Hypertens 2004; 13(2): 225-230.
12. Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol 2003; 60: 223-228.
13. van Beek AH, Sijbesma JC, Jansen RW, Rikkert MG, Claassen JA. Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use. J Alzheimers Dis 2010; 21(2): 519-526.
14. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358(18): 1887-1898.
15. Tinetti ME. Preventing falls in elderly persons. New Engl J Med 2003; 348(1): 42-49.
16. Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension 1992; 19(6 Pt 1): 508-519.
17. Kanemaru A, Kanemaru K, Kuwajima I. The effects of short-term blood pressure variability and nighttime blood pressure levels on cognitive function. Hypertens Res 2001; 24(1): 19-24.
18. Fisher AA, Davis MW, Srikusalanukul W, Budge MM. Postprandial hypotension predicts all-cause mortality in older, low-level care residents. J Am Geriatr Soc 2005; 53(8): 1313-1320.
19. Moretti R, Torre P, Antonello RM, Manganaro D, Vilotti C, Pizzolato G. Risk factors for vascular dementia: hypotension as a key point. Vasc Health Risk Manag 2008; 4(2): 395-402.
20. Shah K, Qureshi SU, Johnson M, Parikh N, Schulz PE, Kunik ME. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. Am J Geriatric Pharmacother 2009; 7(5): 250-261.
21. vanTulder MW, Assendelft WJJ, Koes BW, Bouter LM. Method guidelines for systematic reviews in the Cochrane Collaboration back review group for spinal disorders. Spine 1997; 22(20): 2323-2330.
22. Kume K, Hanyu H, Sakurai H, Takada Y, Onuma T, Iwamoto T. Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease. Geriatrics Gerontol Int 2012; 12: 207-214.
23. Ohrui T, Tomita N, Sato-Nakagawa T, Matsui T, Maruyama M, Niwa K et al. Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology 2004; 63: 1324-1325.
24. Morich FJ, Bieber F, Lewis JM, Kaiser L, Cutler NR, Escobar JI et al. Nimodipine in the Treatment of Probable Alzheimer's Disease. Clin Drug Invest 1996; 11(4): 185-195.
25. Pantoni L, del Ser T, Soglian AG, Amigoni S, Spadari G, Binelli D et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebocontrolled trial. Stroke 2005; 36: 619-624.
26. Sze KH, Sim TC, Wong E, Cheng S, Woo J. Effect of nimodipine on memory after cerebral infarction. Acta Neurologica Scandinavica 1998; 97: 386-392.
27. Wang R, Lagakos S, Ware J, Hunter D, Drazen J. Statistics in Medicine-Reporting of Subgroup Analyses in Clinical Trials. New Engl J Med 2007; 357(21): 2189-2194.
28. Feise R. Do multiple outcome measures require P-value adjustment? BMC Med Res Methodol 2002; 2(1): 8.
29. Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med 2012; 172(15): 1162-1168.
30. Sabayan B, Oleksik A, Maier A, van Buchem M, Poortvliet R, de Ruijter W et al. High blood pressure and resilience to physical and cognitive decline in the oldest old: The Leiden 85-Plus Study. J Am Geriatrics Soc 2012; 60: 2014-2019.
31. Xie J, Brayne C, Matthews FE. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ 2008; 336: 258-262.
32. Gill TM, Gahbauer EA, Han L, Allore HG. Trajectories of Disability in the Last Year of Life. New Engl J Med 2010; 362(13): 1173-1180.